Literature DB >> 27045751

Enhancement of ACE and prolyl oligopeptidase inhibitory potency of protein hydrolysates from sardine and tuna by-products by simulated gastrointestinal digestion.

Oscar Martínez-Alvarez1, Irineu Batista2, Cristina Ramos2, Pilar Montero1.   

Abstract

This work was focused on the study of the bioactive potential of three fish protein hydrolysates, one of them prepared from industrial sardine by-products (head and viscera) and the others from tuna by-products (head, and muscle and viscera). These protein hydrolysates exhibited moderate ability to inhibit Angiotensin Converting Enzyme or ACE (IC50 between 0.24-1.16 mg dry weight per ml) and prolyl oligopeptidase or PO (IC50 between 3.30-9.57 mg ml(-1)), those obtained from tuna by-products being the most effective. Overall, ACE- and PO-inhibiting activities were enhanced by sequential nanofiltration through 3 and 1 kDa MWCO membranes (IC50 between 0.02-0.16 mg ml(-1) (ACE) and 1.10-4.21 mg ml(-1) (PO)). The inhibitory properties of the hydrolysates were greatly improved by in vitro gastric digestion, and were barely affected by further intestinal digestion. The digested tuna hydrolysates, mainly that from heads, proved to be the best source of PO- and ACE- inhibiting molecules (IC50 = 0.16 mg ml(-1) (ACE) and 1.04 mg ml(-1) (PO)) and could be potential new ingredients in food with interest in the prevention or treatment of cardiovascular and neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27045751     DOI: 10.1039/c5fo01603g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  8 in total

1.  Fish Scale Valorization by Hydrothermal Pretreatment Followed by Enzymatic Hydrolysis for Gelatin Hydrolysate Production.

Authors:  Yiqi Zhang; Dan Tu; Qing Shen; Zhiyuan Dai
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

2.  Identification and Characterization of Edible Cricket Peptides on Hypertensive and Glycemic In Vitro Inhibition and Their Anti-Inflammatory Activity on RAW 264.7 Macrophage Cells.

Authors:  Felicia Hall; Lavanya Reddivari; Andrea M Liceaga
Journal:  Nutrients       Date:  2020-11-23       Impact factor: 5.717

3.  Preparation, Characterization, and Cytoprotective Effects on HUVECs of Fourteen Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides From Protein Hydrolysate of Tuna Processing By-Products.

Authors:  Qian-Qian Qiao; Qian-Bin Luo; Shi-Kun Suo; Yu-Qin Zhao; Chang-Feng Chi; Bin Wang
Journal:  Front Nutr       Date:  2022-04-14

4.  Novel angiotensin-converting enzyme inhibitory peptides from tuna byproducts-milts: Preparation, characterization, molecular docking study, and antioxidant function on H2O2-damaged human umbilical vein endothelial cells.

Authors:  Shi-Kun Suo; Shuo-Lei Zheng; Chang-Feng Chi; Hong-Yu Luo; Bin Wang
Journal:  Front Nutr       Date:  2022-07-22

5.  Optimization of antioxidative peptides from mackerel (Pneumatophorus japonicus) viscera.

Authors:  Xueqin Wang; Huahua Yu; Ronge Xing; Xiaolin Chen; Song Liu; Pengcheng Li
Journal:  PeerJ       Date:  2018-02-15       Impact factor: 2.984

6.  Tryptophan-Containing Dual Neuroprotective Peptides: Prolyl Endopeptidase Inhibition and Caenorhabditis elegans Protection from β-Amyloid Peptide Toxicity.

Authors:  Paloma Manzanares; Roberto Martínez; Sandra Garrigues; Salvador Genovés; Daniel Ramón; Jose F Marcos; Patricia Martorell
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

Review 7.  Exploiting of Secondary Raw Materials from Fish Processing Industry as a Source of Bioactive Peptide-Rich Protein Hydrolysates.

Authors:  Girija Gajanan Phadke; Nikheel Bhojraj Rathod; Fatih Ozogul; Krishnamoorthy Elavarasan; Muthusamy Karthikeyan; Kyung-Hoon Shin; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2021-08-25       Impact factor: 5.118

8.  Preparation, Identification, Molecular Docking Study and Protective Function on HUVECs of Novel ACE Inhibitory Peptides from Protein Hydrolysate of Skipjack Tuna Muscle.

Authors:  Shuo-Lei Zheng; Qian-Bin Luo; Shi-Kun Suo; Yu-Qin Zhao; Chang-Feng Chi; Bin Wang
Journal:  Mar Drugs       Date:  2022-02-27       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.